Is Trouble Brewing at Aphria (TSX:APHA)?

Aphria Inc (TSX:APHA)(NYSE:APHA) has fallen sharply over the past month and the decline may not be over just yet.

question marks written reminders tickets

Image source: Getty Images

Aphria Inc (TSX:APHA)(NYSE:APHA) has been under a lot of scrutiny lately with the controversy surrounding a potential deal with Green Growth Brands, disappointing quarterly results, and changes in management all creating a lot of negative press for the company.

Early in the year, the company announced that CEO Vic Neufeld would be transitioning out of his position. However, Aphria is still trying to find someone for that role, and in the meantime, President Jakob Ripshtein is resigning from his position and will be leaving the company in early June. Ripshtein has been with the company a year, previously working with Diageo, a company that’s shown interest in the cannabis beverages market.

Under normal circumstances, a resignation wouldn’t necessarily mean bad news for a company. People leave positions all the time for better opportunities. However, for Aphria, it’s just another sign that perhaps things aren’t going as well as everyone would have expected. One of the reasons Neufeld cited for leaving his role was due to health, and the company likely did add a lot of stress given the pressure it had been under during his tenure.

Aphria has typically been one of the more poor-performing pot stocks in the industry, and in a little more than a month the share price has fallen by over 30% after a big loss in Q3 spooked many investors. With the news of Ripshtein leaving, it could cause even more concern for the stock, as we could see the tailspin continue indefinitely.

Should investors be worried?

While it may prove tempting to buy the stock given the significant drop in value that we’ve seen recently, investors shouldn’t ignore the warning signs. Ripshtein leaving the president role after taking it over just six months ago suggests to some big problems. While we’ll likely never know the reason for his departure, given that he left a high-ranking position with a big company to relocate to Canada, it should raise some big flags.

The facts certainly suggest that something is not going well at Aphria and that investors might be in for more troubled times ahead.

Impact on edibles

The edibles market is just five months away from becoming legal, and with Aphria losing an executive with lots of experience in beverages and no key partner from that industry to help it with development and research, there are some valid concerns about whether the company will be ready. There’s been little reason for investors to get excited about Aphria, and this news raises even more question marks about the company’s future.

Bottom line

Where there’s smoke, there’s usually fire, and Aphria has been putting out a lot of fires lately. It’s never good for a company to be consistently making negative headlines, and as much as I may believe that the company will recover in the long term, today there’s simply too much risk and too many question marks surrounding Aphria.

Although the stock is a tempting buy on the dip, the danger is that the dip could turn out to be a complete collapse. Aphria is still well above its 52-week low of $4.76 and I wouldn’t be surprised if the stock continues to spiral downward in price.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Canopy Growth Stock Surged 100% Last Month: Is It a Good Buy Now?

Canopy Growth soared more than 160% last month. Can the TSX cannabis stock continue to mover higher in 2024?

Read more »

A cannabis plant grows.
Cannabis Stocks

Canopy Growth Stock Is Rising But I’m Worried About This One Thing

Canopy Growth stock is soaring as the legalization effort makes real progress in both Germany and the United States.

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Why Canopy Growth Stock Could Double in 2024

Canopy Growth (TSX:WEED) stock saw its share more than double in the last two weeks. So, can it do it…

Read more »

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

Why Canopy Growth Stock Jumped 16% on Wednesday

Canopy Growth stock (TSX:WEED) is up 16% on Wednesday, adding to a surge of 60% growth in the last week…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Is the Worst Over for Canopy Growth Stock?

Down 99% from all-time highs Canopy Growth stock has burnt investor wealth and remains a high-risk investment.

Read more »